Home › Device types › QDS
Mers-Cov And Common Respiratory Pathogens Semi-Quantitative And Quantitative Multiplex Nucleic Acid Detection System
FDA product code QDS · Class 2 · Pathology
2
Registered devices
7
Adverse events
5
Recalls
3
510(k) clearances
Devices with this code
Recent recalls
| Date | Firm | Reason |
|---|---|---|
| 2025-02-27 | BioFire Diagnostics, LLC | Increased risk of control failures and false negative test results with multiplexed nucleic acid test. |
| 2024-06-10 | BioFire Diagnostics, LLC | Pneumonia panels have an increased risk of control failures due to an issue in the manufacturing process, which could lead to delayed results for the customer. |
| 2024-06-10 | BioFire Diagnostics, LLC | Pneumonia panels have an increased risk of control failures due to an issue in the manufacturing process, which could lead to delayed results for the customer. |
| 2023-12-14 | BioFire Diagnostics, LLC | Their is a potential for false positive results when using Pneumonia panel. |
| 2021-06-07 | BioFire Diagnostics, LLC | Due to real-time stability study failures resulting in increase rate of false negative results between the 6 to 12 month expiry time-frame. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsSourced from public U.S. FDA data. Informational only — not medical or regulatory advice. Not affiliated with the FDA.
